Research map: Serial amyloid PET demonstrates marked reduction in amyloid burden following donanemab treatment: a real-world cohort study

Back to the article

Papers in this map

  1. NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease · Clifford R. Jack · 2018 · 10916 citations · Cited by this paper
  2. Predictive factors for therapeutic response to radioactive iodine therapy in pulmonary metastases from differentiated thyroid carcinoma · 2026 · Related
  3. Donanemab in Early Symptomatic Alzheimer Disease · John Randall Sims · 2023 · 2897 citations · Cited by this paper
  4. Correlation of tumor maximum standardized uptake value from 18F-BPA PET and boron neutron capture therapy tumor dose with treatment outcomes in head and neck cancer: a retrospective analysis · 2026 · Related
  5. Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup · Clifford R. Jack · 2024 · 2682 citations · Cited by this paper
  6. Dosimetric advantages of non-coplanar volumetric modulated arc therapy (VMAT) using biaxially rotational dynamic radiation therapy compared with coplanar VMAT in prostate stereotactic body radiation therapy with focal boost · 2026 · Related
  7. Donanemab in Early Alzheimer’s Disease · Mark A. Mintun · 2021 · 1779 citations · Cited by this paper
  8. Updates on molecular classification and treatment in endometrial cancer · 2026 · Related
  9. The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET · William E. Klunk · 2014 · 1406 citations · Cited by this paper
  10. Role of extracellular volume fraction determined by dual-layer spectral detector CT in predicting the tumor grade of pancreatic neuroendocrine neoplasms · 2026 · Related
  11. Use of Florbetapir-PET for Imaging β-Amyloid Pathology · Christopher M. Clark · 2011 · 1125 citations · Cited by this paper
  12. Early prediction of joint space narrowing in rheumatoid arthritis using AI-quantified bilateral joint space asymmetry on hand radiography · 2026 · Related
  13. 18 F‐flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial · Rik R. Vandenberghe · 2010 · 655 citations · Cited by this paper
  14. Deep learning-based motion correction: cardiac motion artifact and image quality improvements on chest CT · 2026 · Related
  15. Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions · Victor L. Villemagne · 2018 · 456 citations · Cited by this paper
  16. MRI-based assessment for optimal breast cancer local therapy in the era of BI-RADS v2025 · 2026 · Related
  17. Quantification of amyloid PET for future clinical use: a state-of-the-art review · Hugh Pemberton · 2022 · 230 citations · Cited by this paper
  18. Intravoxel incoherent motion diffusion-weighted imaging for early response stratification of neoadjuvant immune checkpoint inhibitor plus tyrosine kinase inhibitor in renal cell carcinoma: an exploratory study · 2026 · Related
  19. Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup · Gil D. Rabinovici · 2025 · 134 citations · Cited by this paper
  20. Peritumoral fat content using iterative decomposition of water and fat with echo asymmetry and least-squares estimation (IDEAL) is associated with triple-negative breast cancer · 2026 · Related
  21. Software development for quantitative analysis of brain amyloid PET · Hiroshi Matsuda · 2022 · 46 citations · Cited by this paper
  22. Posttreatment Amyloid Levels and Clinical Outcomes Following Donanemab for Early Symptomatic Alzheimer Disease · Ming Lu · 2025 · 28 citations · Cited by this paper
  23. Quantitative Brain Amyloid PET · William J. Jagust · 2024 · 24 citations · Cited by this paper
  24. Toward a Universal Readout for18F-Labeled Amyloid Tracers: The CAPTAINs Study · Gérard N. Bischof · 2021 · 22 citations · Cited by this paper
  25. Comparison of consistency in centiloid scale among different analytical methods in amyloid PET: the CapAIBL, VIZCalc, and Amyquant methods · Cong Shang · 2024 · 22 citations · Cited by this paper
  26. Comparative evaluation of CortexID and VIZCalc software in brain amyloid PET: a retrospective study of 116 cases · Manduukhai Badarchin · 2025 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)